Humeral supracondylar fractures are common injuries, especially in children, and can cause long-term disability if not treated correctly. Treatment of these fractures is complex and requires careful planning and execution to achieve optimal outcomes. This article will discuss the principles of humeral supracondylar fracture treatment and provide strategies for achieving optimal outcomes.
The humerus is the long bone of the upper arm that connects the shoulder to the elbow joint. It is composed of three parts – the head, neck, and shaft. The supracondylar region is the area of the humerus just above the elbow joint. A supracondylar fracture occurs when the humerus bone is broken just above the elbow joint. These fractures can be caused by a direct blow to the elbow, a fall onto an outstretched arm, or a twisting force. The most common type of supracondylar fracture is a transverse fracture, which is a break across the bone. Other types of supracondylar fractures include oblique fractures, which are diagonal breaks, and comminuted fractures, which are multiple pieces of broken bone.
Humeral supracondylar fractures can be classified according to the location of the fracture and the type of displacement. The Gartland classification system is the most commonly used system and classifies fractures into three types: type I, type II, and type III. Type I fractures are nondisplaced fractures, meaning the bone is not out of alignment. Type II fractures are minimally displaced fractures, meaning the bone is slightly out of alignment. Type III fractures are displaced fractures, meaning the bone is significantly out of alignment.
The goal of treatment for humeral supracondylar fractures is to restore the normal anatomy of the humerus and the elbow joint. Treatment is based on the type of fracture and the age of the patient. In general, the treatment of humeral supracondylar fractures involves immobilization of the arm in a cast, splint, or sling. Immobilization helps to reduce pain and protect the fracture from further injury. Surgery may be necessary for certain types of fractures or if the fracture does not heal properly.
Non-operative treatment is the preferred treatment for type I and type II fractures. This involves immobilizing the arm in a cast, splint, or sling for 4 to 6 weeks. The immobilization helps to reduce pain and protect the fracture from further injury. Physical therapy is also recommended to help restore range of motion and strength. The therapist will also teach the patient exercises to help reduce pain and improve function.
Operative treatment is recommended for type III fractures and for some type II fractures. The goal of surgery is to reduce the fracture and restore the normal anatomy of the humerus and the elbow joint. The most common surgical technique is open reduction and internal fixation (ORIF). This involves making an incision over the fracture site and using screws, plates, or pins to hold the bone in place while it heals. Other surgical techniques include external fixation, which involves using pins and rods to hold the bone in place outside the body, and arthroscopy, which involves using a small camera to view and repair the fracture.
Complications of humeral supracondylar fracture treatment can include infection, nerve damage, and nonunion of the fracture. Nonunion occurs when the fracture does not heal properly and can lead to long-term disability.
Humeral supracondylar fractures can cause long-term disability if not treated correctly. Treatment of these fractures is complex and requires careful planning and execution to achieve optimal outcomes. Non-operative treatment, such as immobilization and physical therapy, is the preferred treatment for type I and type II fractures. Surgery is recommended for type III fractures and for some type II fractures. Complications of treatment can include infection, nerve damage, and nonunion of the fracture. With careful planning and execution, optimal outcomes can be achieved in humeral supracondylar fracture treatment.
1.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
2.
Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.
3.
Long-term study links chronic conditions in midlife to higher cancer risk and mortality
4.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
5.
When does a melanoma metastasize? Implications for management
1.
Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results
2.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
3.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
4.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
5.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation